Heather Torrey

468 total citations
10 papers, 363 citations indexed

About

Heather Torrey is a scholar working on Immunology, Oncology and Dermatology. According to data from OpenAlex, Heather Torrey has authored 10 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 4 papers in Oncology and 2 papers in Dermatology. Recurrent topics in Heather Torrey's work include Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (5 papers) and CAR-T cell therapy research (3 papers). Heather Torrey is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (5 papers) and CAR-T cell therapy research (3 papers). Heather Torrey collaborates with scholars based in United States, Canada and Belgium. Heather Torrey's co-authors include Yoshiaki Okubo, John Butterworth, Hui Zheng, Denise L. Faustman, Denise L. Faustman, Danielle Baum, Audrey Defusco, Éva Scheuring Vanamee, Lisa Tran and Rosemary Foster and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Heather Torrey

9 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heather Torrey United States	7	285	108	53	41	25	10	363
Oliver Eltherington United Kingdom	4	251 0.9×	57 0.5×	63 1.2×	21 0.5×	17 0.7×	4	325
Ana deBarros Portugal	7	735 2.6×	142 1.3×	59 1.1×	35 0.9×	15 0.6×	7	789
Christopher M. Borges United States	5	365 1.3×	91 0.8×	87 1.6×	39 1.0×	16 0.6×	7	428
Kirthi R. Kumar United States	9	307 1.1×	39 0.4×	72 1.4×	38 0.9×	24 1.0×	13	407
Myriam Fernández-Sendin Spain	9	139 0.5×	121 1.1×	69 1.3×	37 0.9×	14 0.6×	19	237
Juan Estrada United States	8	81 0.3×	87 0.8×	110 2.1×	22 0.5×	18 0.7×	17	235
Edd Ricker United States	7	230 0.8×	39 0.4×	70 1.3×	30 0.7×	24 1.0×	12	344
Liliane Khoryati France	8	165 0.6×	46 0.4×	24 0.5×	34 0.8×	21 0.8×	13	242
Cécile Déjou France	7	257 0.9×	180 1.7×	78 1.5×	11 0.3×	17 0.7×	9	415

Countries citing papers authored by Heather Torrey

Since Specialization

Citations

This map shows the geographic impact of Heather Torrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Torrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Torrey more than expected).

Fields of papers citing papers by Heather Torrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Torrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Torrey. The network helps show where Heather Torrey may publish in the future.

Co-authorship network of co-authors of Heather Torrey

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Torrey. A scholar is included among the top collaborators of Heather Torrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Torrey. Heather Torrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Dorigo, Oliver, Amit M. Oza, Tanja Pejović, et al.. (2023). Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial. Clinical Cancer Research. 29(15). 2808–2815. 7 indexed citations

Yang, Michael B., Lisa Tran, Heather Torrey, et al.. (2020). Optimizing TNFR2 antagonism for immunotherapy with tumor microenvironment specificity. Journal of Leukocyte Biology. 107(6). 971–980. 19 indexed citations

Torrey, Heather, Genevieve Weir, Ann R. Falsey, et al.. (2020). Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein. Human Vaccines & Immunotherapeutics. 16(9). 2007–2017. 6 indexed citations

Torrey, Heather, Willem M. Kühtreiber, Yoshiaki Okubo, et al.. (2020). A novel TNFR2 agonist antibody expands highly potent regulatory T cells. Science Signaling. 13(661). 47 indexed citations

Torrey, Heather, Michael S. Khodadoust, Lisa Tran, et al.. (2018). Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome. Leukemia. 33(5). 1206–1218. 49 indexed citations

Torrey, Heather, Audrey Defusco, Danielle Baum, et al.. (2018). Abstract B18: Novel treatment of cutaneous T cell lymphoma: Targeting TNFR2, an oncogene and marker of potent Tregs, with anti-TNFR2 antibodies. Cancer Immunology Research. 6(9_Supplement). B18–B18. 1 indexed citations

Weir, Genevieve, et al.. (2018). Abstract 1726: A novel delivery platform containing up to 14 neoantigens can induce robust immune responses in a single formulation. Cancer Research. 78(13_Supplement). 1726–1726. 1 indexed citations

Faustman, Denise L., Heather Torrey, John Butterworth, et al.. (2017). Targeting the TNFR2 oncogene on tumor cells and tregs of the tumor microenvironment via dominant TNFR2 antagonism.. Journal of Clinical Oncology. 35(7_suppl). 106–106.

Torrey, Heather, John Butterworth, Toshiyuki Mera, et al.. (2017). Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated T _regs. Science Signaling. 10(462). 147 indexed citations

10.

Okubo, Yoshiaki, Heather Torrey, John Butterworth, Hui Zheng, & Denise L. Faustman. (2016). Treg activation defect in type 1 diabetes: correction with TNFR2 agonism. Clinical & Translational Immunology. 5(1). e56–e56. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact